Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
32
Participants
Timeline
Start Date
October 31, 2000
Primary Completion Date
March 31, 2004
Conditions
Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial CancerStage IV Ovarian Epithelial Cancer
Interventions
DRUG
bryostatin 1
Given IV
DRUG
cisplatin
Given IV
OTHER
laboratory biomarker analysis
Correlative studies
Trial Locations (1)
91010
City of Hope, Duarte
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00006942 - Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter